Diagnosis and Management of Thymic Neuroendocrine Tumors: A Case Series Review
#258
Introduction: Thymic neuroendocrine tumors (TNET) represent rare types of thymic tumors with an incidence of 0.01/100000 per year. They commonly show rapid disease progression and are rarely curable.
Aim(s): To review retrospectively all cases of TNETs treated in our Unit, focusing on initial presentation, treatment and survival.
Materials and methods: Seven cases (five female, two male) with full follow-up were included. Mean age at diagnosis was 52.4 (range 33-66). Histology was available in six patients. Five met the WHO histological criteria for TNET, and one thymic carcinoma with neuroendocrine features. All patients underwent CT, Octreoscan (or Ga-68octreotate PET) ±123 MIBG scan at diagnosis/follow-up
Conference: 8th Annual ENETSConcerence (2011)
Presenting Author:
Authors: Akay E, El-Khouly F, Khan M, Caplin M, Toumpanakis C,
Keywords: thymic, thymic neuroendocrine tumor, radical thymectomy, chemotherapy, somatostatin analogues, Y-90,
To read the full abstract, please log into your ENETS Member account.